as 12-23-2024 9:50am EST
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
Founded: | 2013 | Country: | United States |
Employees: | N/A | City: | DALLAS |
Market Cap: | 28.3M | IPO Year: | N/A |
Target Price: | $4.50 | AVG Volume (30 days): | 5.4M |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.65 | EPS Growth: | N/A |
52 Week Low/High: | $0.82 - $3.72 | Next Earning Date: | 11-06-2024 |
Revenue: | $27,264,000 | Revenue Growth: | 44.52% |
Revenue Growth (this year): | 62.68% | Revenue Growth (next year): | -19.08% |
MDAI Breaking Stock News: Dive into MDAI Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
GlobeNewswire
11 days ago
GlobeNewswire
14 days ago
GlobeNewswire
21 days ago
MT Newswires
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
The information presented on this page, "MDAI Spectral AI Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.